Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Beginning Cash Balance: 2009-2025

Historic Beginning Cash Balance for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $16.1 million.

  • Cumberland Pharmaceuticals' Beginning Cash Balance fell 7.21% to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.5 million, marking a year-over-year decrease of 5.64%. This contributed to the annual value of $18.3 million for FY2024, which is 7.27% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Beginning Cash Balance is $16.1 million, which was up 6.48% from $15.1 million recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Beginning Cash Balance high stood at $27.0 million for Q1 2022, and its period low was $15.1 million during Q2 2025.
  • Over the past 3 years, Cumberland Pharmaceuticals' median Beginning Cash Balance value was $18.0 million (recorded in 2025), while the average stood at $17.6 million.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Beginning Cash Balance plummeted by 30.72% in 2022, and later climbed by 13.20% in 2024.
  • Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Beginning Cash Balance stood at $25.8 million in 2021, then decreased by 24.38% to $19.5 million in 2022, then dropped by 5.29% to $18.5 million in 2023, then declined by 5.64% to $17.5 million in 2024, then decreased by 7.21% to $16.1 million in 2025.
  • Its Beginning Cash Balance was $16.1 million in Q3 2025, compared to $15.1 million in Q2 2025 and $18.0 million in Q1 2025.